Compound Ranitidine Capsules

This product is a compound preparation, in which ranitidine is an H2 receptor blocker, which can inhibit the basic gastric acid and gastric acid secretion caused by gastrin stimulation, and reduce the activity of gastric acid and pepsin. Potassium bismuth citrate forms a diffuse protective layer covering the mucosal surface in the acidic environment of the stomach, preventing gastric acid, enzymes and food from invading the mucosa. This product also has the effect of reducing pepsin activity, increasing mucin secretion, and promoting the release of prostaglandins from the mucosa, thereby enhancing the defense of the gastric mucosa. In addition, potassium bismuth citrate also has a certain killing effect on Helicobacter pylori, so this product can promote the healing of lesions.

Ranitidine hydrochloride and bismuth potassium citrate.

This product is a capsule, and the contents are light yellow granules or powder.

Used for chronic gastritis and to relieve stomach pain, heartburn and acid reflux caused by excessive gastric acid.

Oral administration: Adults take 1 capsule each time, twice a day. The course of treatment should not exceed 6 weeks. The dosage and course of treatment combined with antibiotics should be as prescribed by the doctor.

1 Common symptoms include nausea, constipation, rash, fatigue, headache, and dizziness. 2 During medication, there may be an ammonia smell in the mouth, and the tongue coating and stool may turn gray and black, which will disappear on its own after stopping the medication. 3 The adverse reactions to renal function, gonadal function, and the central nervous system are milder than those of cimetidine.

1. Patients with severe renal insufficiency are prohibited from using this product. 2. Pregnant women are prohibited from using this product.

Precautions for children: Not recommended for children. Precautions for pregnancy and lactation: Contraindicated for pregnant women. Precautions for the elderly: Not clear yet.

1. Milk and other antacids can interfere with the effect of this product and should not be taken at the same time. 2. This product can affect the absorption of tetracyclines and should not be taken at the same time. 3. If used with other drugs at the same time, drug interactions may occur. Please consult a doctor or pharmacist for details.

Keep away from light, tightly sealed, and stored in a cool and dry place.

Each tablet contains 150 mg of ranitidine hydrochloride and 110 mg of bismuth potassium citrate (calculated as bismuth)

24 months.

Suzhou Dawnrays Pharmaceutical Co., Ltd.

• Founded in:

  1995-12-08

• Address:

  No. 268, Minfeng Road, Wuzhong Economic Development Zone, Suzhou

• Tax NO.:

  913205006283933800

• Registered Funds:

  $131.5 million

• Website:

  Log in to view

• Email:

  Log in to view